TCMD - NASDAQ
Tactile Systems Technology, Inc.
$24.37
-0.16%Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
At a Glance
Live SnapshotTactile Systems Technology, Inc. Management Team
Ms. Sheri Louise Dodd
Chief Executive Officer, President & Director
Compensation
$936,850
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Compensation
$647,900
Janelle M. Strop
Chief Human Resource Officer
Mr. John David Kaercher
Chief Information Officer
Dr. Antonios P. Gasparis F.A.C.S., M.D.
Chief Medical Officer & Member of Vascular Strategic Advisory Board
Mr. Jerry A. Sauber
Senior Vice President of Manufacturing, Operations, R&D
Ms. Kristie T. Burns
Senior Vice President of Marketing & Clinical Affairs
Compensation
$559,470
Aaron R. Snodgrass
Senior Vice President of Sales
Ms. Sunday J. Hoy Esq.
Vice President of Regulatory Affairs & Chief Compliance Officer
Tactile Systems Technology, Inc. Insider Positioning
During the last 12 months, insiders have sold $1.23M worth of TCMD shares, with no buying activity reported.
3 Months
0
0.00
4.6K
113.40K
-113K
-$113K
3-6 Months
0
0.00
35.4K
1.02M
-1.0M
-$1.02M
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
7.8K
95.91K
-96K
-$96K
Top Buyers
No buying activity
Top Sellers
Birkemeyer Elaine M.
Officer: Chief Financial Officer
$487K
Dodd Sheri Louise
Director, Officer: Chief Executive Officer
$414K
Burns Kristie
Officer: Sr. Vp Mktg & Clinical Affairs
$329K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $1.23M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
TCMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 25, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 28, 2025 | May 07, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 27, 2024 | May 08, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 27, 2023 | March 27, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 28, 2022 | May 09, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 05, 2021 | May 17, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 19, 2020 | May 07, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 26, 2019 | May 09, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 27, 2018 | May 10, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 24, 2017 | May 09, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.